One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction

Heart

Volumn 93, Issue 7, 2007, Pages 837-841

  Penicka, M ^a   Lang, O ^a   Widimsky, P ^a   Kobylka, P ^b   Kozak, T ^c   Vanek, T ^a   Dvorak, J ^a   Tintera, J ^d   Bartunek, J ^e  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^e OLV HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BONE MARROW CELL; CELL KINETICS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ENGRAFTMENT; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; MALE; MOLECULAR DYNAMICS; MONONUCLEAR CELL; PRIORITY JOURNAL; RISK FACTOR;

ACUTE DISEASE; AGED; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CORONARY VESSELS; GRAFT SURVIVAL; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHARMACOKINETICS; RADIOPHARMACEUTICALS; STROKE VOLUME; TECHNETIUM TC 99M EXAMETAZIME;

EID: 34250003859     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.091934     Document Type: Article

References (20)

1. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet 2004;364:141-8.
2. Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-8.
3. Barbash IM, Chouraqui P, Baron J, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, body distribution. Circulation 2003;108:863-8.
4. Aicher A, Brenner W, Zuhayra M, et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003;107:2134-9.
5. Hou D, Youssef EA, Brinton TJ, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005;112(Suppl 1):1-150-6.
6. Peters AM, Danpure HJ, Osman S, et al. Clinical experience with 99mTc-hexamethyl-propyleneaminoxime for labeling leukocytes imaging inflammation. Lancet 1986;2:946-9.
7. Taylor A, Schuster DM, Alazraki N. A clinician's guide to nuclear medicine. Reston, VA: Society of Nuclear Medicine, 2000:212.
8. Eaves CJ. Assays of hemopoietic progenitor cells. In: B Ernest, eds. Williams hematology. New York: McGraw Hill, 1995:22-6.
9. Saito T, Kuang JQ, Lin CC, et al. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction. J Thorac Cardiovasc Surg 2003;126:114-23.
10. Damȧs JK, Wæhre T, Yndestad A, et al. Stromal cell-derived factor-1 in unstable angina: potential anti-inflammatory and matrix-stabilizing effects. Circulation 2002;106:36-42.
11. Papayannopoulou T. Bone marrow homing: the players, the playfield, and their evolving roles. Curr Opin Hematol 2003;10:214-19.
12. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through hif-1 induction of sdf-1. Nat Med 2004;10:858-64.
13. De Falco E, Porcelli D, Torella AR, et al. Sdf-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004;104:3472-82.
14. Wojakowski W, Tendera M, Michalowska A, et al. Mobilization of CD34/ CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004;110:3213-20.
15. Hofmann M, Wollert KC, Meyer GP, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005;111:2198-202.
16. Blocklet D, Toungouz M, Berkenboom G, et al. Myocardial homing of non mobilized peripheral-blood CD34+ cells after intra-coronary injection. Stem Cells 2006;24:333-6.
17. Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-8.
18. Bartunek J, Wijns W, Heyndrickx GR, et al. Timing of intracoronary bone-marrow-derived stem cell transplantation after ST-elevation myocardial infarction. Nat Clin Pract Cardiovasc Med 2006;3(Suppl 1):S52-6.
19. Strauer BE, Brehm M, Zeus T, et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease. The IACT Study. J Am Coll Cardiol 2005;46:1651-8.
20. Botti C, Negri D, Seregni E, et al. Comparison of three different methods for radiolabelling human activated T lymphocytes. Eur J Nucl Med 1997;24:497-504.